drugset / Trial / NCT02684071

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

NCT02684071 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to test an experimental treatment method for recurrent or progressive brain tumors in children aged from 0-22 years. The use of methotrexate and chemotherapy (topotecan and cyclophosphamide) is experimental in this study. This means that their use by themselves or together has not been approved by the U.S. Food and Drug Administration for this usage.

Timeline

Start
2016-02
Primary completion
2019-12-09
Completion
2019-12-09

Outcome

Outcome not reported

Stopped (Business): “Lack of additional funding; patients (3) no longer receiving intervention.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified — Intravenous
Subject Methotrexate Small molecule — Intrathecal
Subject Topotecan Small molecule — Intravenous